Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Change in Account Payables (2022 - 2025)

Praxis Precision Medicines (PRAX) has 4 years of Change in Account Payables data on record, last reported at -$6.2 million in Q4 2025.

  • For Q4 2025, Change in Account Payables fell 149.56% year-over-year to -$6.2 million; the TTM value through Dec 2025 reached $12.1 million, up 80.2%, while the annual FY2025 figure was $12.1 million, 80.2% up from the prior year.
  • Change in Account Payables reached -$6.2 million in Q4 2025 per PRAX's latest filing, down from $2.0 million in the prior quarter.
  • Across five years, Change in Account Payables topped out at $10.4 million in Q1 2025 and bottomed at -$9.0 million in Q2 2023.
  • Average Change in Account Payables over 4 years is $865437.5, with a median of $546500.0 recorded in 2023.
  • Peak YoY movement for Change in Account Payables: crashed 519.89% in 2023, then soared 883.67% in 2024.
  • A 4-year view of Change in Account Payables shows it stood at $4.6 million in 2022, then plummeted by 128.55% to -$1.3 million in 2023, then crashed by 91.07% to -$2.5 million in 2024, then crashed by 149.56% to -$6.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Account Payables were -$6.2 million in Q4 2025, $2.0 million in Q3 2025, and $5.9 million in Q2 2025.